Paolo Fava
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino(IT)Department of Medical Sciences(RU)Department of Medical Sciences(BY)University of Turin(IT)
Publications by Year
Research Areas
Cutaneous lymphoproliferative disorders research, Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model(2015)414 cited
- → Targeting the ERK Signaling Pathway in Melanoma(2019)173 cited
- → Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium(2017)134 cited
- → Time course, clinical pathways, and long‐term hazards risk trends of disease progression in patients with classic mycosis fungoides(2012)126 cited
- → Radiotherapy and immune checkpoints inhibitors for advanced melanoma(2016)99 cited
- → Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study(2018)